Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 19 February 2009, doi:10.1136/bmj.b557
Cite this as: BMJ 2009;338:b557
May be trading better cosmetic outcomes for worse rates of cure
| The first 150 words of the full text of this article appear below. |
Both oncological principles and aesthetic outcomes need to be considered when planning surgery for breast cancer. As breast conserving therapy has evolved over the past 30 years from a radical idea to an accepted standard, and as options for breast reconstruction have increased, the surgical literature has become increasingly devoted to new techniques to improve cosmetic outcomes. "Minimally invasive breast surgery" and "oncoplastic breast surgery" are the new buzzwords among breast surgeons. But what do they mean? And more importantly, how should such procedures be evaluated?
Oncoplastic surgery has been described as "the seamless joining of the extirpative and reconstructive aspects of breast surgery performed by a single surgeon,"1 and those in the field agree that the purpose of oncoplastic surgery is to improve cosmetic outcomes.2 Minimally invasive breast surgery includes techniques of breast conserving surgery, mastectomy, sentinel node biopsy, and axillary dissection. Although initially breast conserving surgery and sentinel
Monica Morrow, chief of breast service and Anne Burnett Windfohr chair in clinical oncology
1 Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
morrowm@mskcc.org
Read all Rapid Responses